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Abstract 
Rats bearmg the fast-growmg AH-l 30 Yoslnda ascItes hepatoma showed a marked cachectlc response which has been previously reported [Tessltore 
et al (1987) Blochem J 241, 153-1591 Thus tumour-bearmg ammals showed slgmficant decreases m body and muscle weight (soleus and 
gastrocnemms) as compared to both pair-fed and ad hbltum-fed animals These decreases were related to an enhanced proteolytlc rate m the muscles 
of the tumour-bearmg ammals as measured by the tyrosme released m m vitro assays In an attempt o elucidate which proteolytlc system IS directly 
responsible for the decrease m muscle mass, we have studied both lysosomal and non-lysosomal (ATP-dependent) proteolytlc systems m this animal 
model While the enzymatic activities of the mam cathepsm (B and B + L.) systems were actually decreased m gastrocnemms muscles of tumour- 
bearmg rats, thus mdicatmg that lysosomal proteolysls was not involved, the ublqmtm pools (both free and conjugated) were markedly altered as 
a result of tumour burden These were associated with an increased ublqmtm gene expression m muscle of tumour-beanng rats, over 500% m relation 
to non-twnour bearers, thus suggesting that the ATP-dependent proteolytlc system may be responsible for the muscle proteolysls and wastage 
observed m this animal tumour model The fact that we have previously shown that TNF enhances the ublqultmlzation of muscle proteins 
[Garcia-Martinez et al (1993) FEBS Lett 323, 21 l-2141, together with the high clrculatmg levels of TNF detected m rats bearmg the Yoshlda 
hepatoma llows us to suggest hat the cytokme may be responsible, most probably mdlrectly, for the activation of the referred proteolytlc system 
m tumour-bearing rats 
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1. Introduction 
The loss of body weight and development of cachexla 
are common signs associated with neoplastlc diseases 
Cachexia 1s a poorly understood syndrome characterized 
by anorexia, weight loss, profound metabolic abnormal- 
ities and progressive host wasting which may result m 
death [32,47,51]. Tissue wasting mvolves mainly adipose 
tissue and skeletal muscle Numerous reports attribute 
the cachectlc state of the host to cytokmes released as a 
result of mvaslve stlmuh (see [ 151 for review). However, 
while the role of cytokmes, particularly tumour necrosis 
factor-a (TNF), on adipose tissue dlssolutlon seems to 
be clear [14,42,45], the effects of the cytokme on muscle 
metabolism lead to more confusing results (see [5] for 
review). TNF 1s a molecule belonging to a polypeptide 
network made up of several cytokmes and growth fac- 
tors that have wide and vaned effects on the growth, 
differentlatlon, and functions of lmune system and 
normal cells [6,41] It 1s produced pnmanly by activated 
macrophages m response to mvaslve stimuli 
* Correspondmg author 
Muscle wasting 1s generally accepted to be caused by 
an mcrease m protein breakdown Chronic treatment of 
rats with recombinant TNF resulted m depletion of body 
protein compared with pair-fed control ammals [52] In- 
deed, chronic treatment with either recombinant TNF or 
mterleukm- 1 -/-I (IL- 1) resulted m a body protein redlstn- 
butlon and a slgmficant decrease m muscle protein con- 
tent associated with coordinate decreases m muscle 
mRNA levels for myofibnllar protems [19] Studies m- 
volvmg admmlstratlon of recombinant TNF m vlvo have 
shown an increase m nitrogen efllux from skeletal muscle 
of non-weight losing humans with dlssemmated cancer 
[54] Flores et al [18], by mfusmg [14C]-leucme mto rats, 
showed that chronic recombinant TNF admmlstratlon 
significantly enhanced muscle protein breakdown Con- 
versely, the admmlstratlon of an acute TNF dose to rats 
did not induce an enhanced proteolysls m soleus or EDL 
muscles subsequently incubated [30] Moldawer et al 
[40] admmlstered recombinant IL-l to mice and ob- 
served, after mcubatmg then EDL muscles, that there 
was an increase in PGE, productlon although the rates 
of both protein synthesis and degradation were unaf- 
fected, thus concluding that the rise m PGE, was not 
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associated with changes m protein turnover. Recently, 
Goodman [25], measuring both tyrosme and 3-methyl- 
hlstldme release by incubated rat muscles of animals 
acutely treated with the cytokme. concluded that TNF 
was mvolved m activating muscle proteolysls The rea- 
sons for these confllctmg results are not clear We have 
recently demonstrated that TNF treatment results m ac- 
tivated muscle proteolysls [20,33,34] and that the prote- 
olytlc system involved m this response seems to be asso- 
ciated with ublqultmlzatlon of muscle protems [21] 
In fact, the precise mechanism by which mtracellular 
proteins are degraded 1s largely unknown, although It 1s 
accepted that proteolysls can occur both mslde and out- 
side of lysosomes.In particular lysosomlc protemases, 
mainly cathepsms do not seem to be involved m the 
degradation of myofibrlllar proteins m rat skeletal mus- 
cle [35] Ublqmtm, a 8600 d peptlde, 1s involved m the 
targeting of proteins undergoing cytosohc ATP-depend- 
ent proteolysls In the cell, ublqultm can be found free 
or conjugated in an lsopeptlde linkage to other cellular 
proteins Proteins with multiple ublqultms are the ones 
targeted for degradation by an ATP-dependent protease 
[ 11 ,16,17,28] The ublqultm system 1s postulated to ac- 
count for the turnover of ‘short-lived’ normal protems 
[ 121, and abnormal proteins formed during stress such as 
heat-shock [8] There are two kinds of ublqmtm-encod- 
mg genes one has multiple ublqultm sequences m the 
form of contiguous repeats of the coding sequence and 
the other encode ublqultm fusion proteins These two 
kinds of genes are differentially expressed whereas the 
ublqultm fusion transcripts are most abundant m normal 
dlvldmg cells, high levels of polyublqultm transcripts are 
found m cells that undergo sporulatlon. dlfferentlatlon 
or, m general, are under stress [7] 
Growth of the as&es hepatoma AH- 130 m rats ehclts 
an early and conspicuous loss of body weight and skele- 
tal muscle mass, associated with a protein hypercatabohc 
state m host tissues [50] as well as profound perturba- 
tions m hormonal homeostasls, an elevation of plasma 
prostaglandm E, and the presence of cn-culatmg TNF 
[ 131. Bearing m mmd the fact that TNF seems to enhance 
muscle proteolysls by increasing the ublqultmlzatlon of 
proteins, we decided to mvestlgate the role of the ublq- 
ultm system m this cachectlc tumour model where the 
endogenous production of the cytokme 1s high as a result 
of tumour burden 
2. Experimental 
2 I Anrmals 
All animals (female Wistar rats) were fed on a chow diet consistmg 
(by weight) of 54% carbohydrate, 17% protein and 5% fat (the residue 
was non-digestible matenal) with free access to drmkmg water, and 
were maintained at an ambient emperature of 22 ? 2°C with a 12 h 
hght/l2 h dark cycle (hghts on from 08 00 h) Food intake and body 
weight were measured ally after tumour moculatlon Pair-fed controls 
were non-tumour bearing animals which were offered the same amount 
of food as that eaten by the tumour bearers the previous day For the 
estimation of proteolytlc rates m isolated soleus muscles, smaller am- 
mals were used (60-70 g) so that their muscles could be incubated 
whole, without bemg under anoxla 
2 2 Blochenucals 
All enzymes and coenzymes were either obtained from Boehrmger 
Mannhelm, S A (Barcelona, Spain) or from Sigma Chemical (St 
Louis, USA) Cathepsm substrates were purchased from Bachem 
(Bubendorf, Switzerland) Recombinant-denved TNF was generously 
gven by BASF-Knoll A G (Ludwigshafen, Germany) Polyclonal rab- 
bit anti-rat-ubiqmtm was provided by Dr Arthur L Haas, Department 
of Biochemistry, Medlcal College of Wsconsm, Milwaukee (Wlscon- 
sm. USA) 
2 3 Tumour rmplantatron 
A Yoshlda AH-130 ascites hepatoma cell suspension (approx 10” 
cells m 2 ml) was injected mtrapentoneally, the control rats being 
injected with 2 ml of 0 9% (w/v) NaCl solution The Yoshlda AH-130 
1s a rapidly growing tumour with a volume doubling time of 1 day [SO] 
Total cell content was estimated using Trypan blue stammg Food 
intake and body weight were measured aily after tumour maculation 
2 4 Muscle preparatrons and mcubatlons 
The dissection and isolation of the soleus muscles was carried out 
under pentobarbital anaesthesia s previously described [26] The iso- 
lated muscles were fixed to a stainless-steel chp m order to mamtam the 
muscle under slight tension (making It comparable to resting length) 
during the mcubation Such muscles are able to mamtam normal ATP 
and phosphocreatme concentrations during a 3 h incubation period 
The muscles were incubated m a shaking-thermostatized water bath at 
37°C for 3 h m 3 ml of Krebs-Henseleit physiological saline pH 7 4, 
containing 5 mM glucose, bovine serum albumm (1 mg/ml) and 20 mM 
HEPES After the addition of the muscles to the vials, these were 
stoppered and the incubation started at a shaking rate of 45 cycles/nun 
Vials were gassed with O,/CO, 19 1 during the whole mcubatlon period 
The incubation medium was kept for no longer than 90 mm and was 
renewed thereafter with fresh me&urn with the same composition as 
described above 
2 5 Proteolytu rate UI zsolated muscles 
Total protein degradation by the isolated muscles was calculated as 
the rate of tyrosme released mto the medium m the presence of 0 5 mM 
cycloheximlde to block the remcorporation of tyrosme into tissue pro- 
tem Tyrosme was measured fluonmetrically as previously described 
[531 
2 6 Isobrron and preparation ofmuycle tzsue for quantifcatron of free 
and conjugated ubrqwtm 
The soleus and gastrocnenuus were removed under pentobarbital 
dnaesthesla Excised muscles were quickly weighed and rapidly frozen 
m hqmd N, Ubiqmtm pools m muscle extracts were determined by 
Imm;noche-rnical &aly& Individual muscles were finely homogenized 
using a Polytron homogenizer m 2 ml of ice-cold 50 mM Tns-HCI 
buffer containing 0 25 mM sucrose, 5 mM EDTA. 1% (w/v) sodium 
dodecyl sulphate, 0 1 trypsm mlubltor unit/ml aprotmm, 1 PM leu- 
peptm, 1 PM pepstatm, 5 mM N-ethylmalenmde and 1 mM PMSF, 
pH 7 4 The resultmg homogenates were centrifuged at 4OC for 20 mm 
at 15 000 x g to remove cell debris Ahquots of the supernatants were 
stored at -80°C Protem content was measured using the Bradford 
assay [9] using bovine serum albumm as a standard 
2 7 Western blots 
Ahquots of the supernatants were diluted with 0 5 volumes of 30 mM 
phosphate buffer pH 7 0 contammg 7 5% (w/v) sodium dodecyl 
sulphate and 0 15% (w/v) dithlotreitol, 0 05% (w/v) Bromophenol blue 
and 30% glycerol Samples were boiled for 5 mm, 50 pg of protem- 
samples being assayed for ubiqmtm conJugates Sodium dodecyl 
sulphdte (SDS)-15% polyacrylanude gel electrophoresls was performed 
on muscle samples Protems were transferred to Immobllon m 25 mM 
Tns buffer containing 144 mM glycme, 25% methanol, 0 02% SDS for 
12 h The filter was blocked foi i h at room temperature m buffer A 
(25 mM Tns-HCI nH 7 5. 150 mM NaC1, 25 mn/ml BSA and 0 02% 
sodium azide) and &cubated for 90 mm with a ant;ublqultm polyclondl 
antibody which recognized free and conjugated ublqmtm at d concen- 
tratlon of IO pg/ml m buffer A Detection of antIbody-antigen com- 
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plexes was carned out using [“‘Ilprotem A according to standard pro- 
cedures Quantltation of the different autoradlographs was done by 
densitometry using a scanning microdensitometer Data for both free 
and conjugated ublqmtm were normahzed to extract protein concentra- 
tion determined by the Bradford assay [9] 
2 8 RNA zsolatlon and Northern blot analym 
Total RNA from gastrocnemms muscles was extracted usmg the acid 
guamdmmm Isotluocyanate/phenol/chloroform method as described 
by Chomczynskl and Sac& [lo] and quantified by absorbance at 
260 nm 
RNA samples (40 pg) were denatured, subject to electrophoresls m 
1 2% agarose gels containing 6 3% formaldehyde and transferred to 
Hybond H membranes (Amersham) RNA was fixed to membranes by 
lllummatmg with UV light for 4 mm The RNA m gels and in filters 
was vlsuahzed with ethichum bromide and photographed by UV transll- 
lummatlon to ensure the integrity of RNA, to check the loading of 
equivalent amounts of RNA and to confirm proper transfer RNA was 
transferred m 10 x standard saline citrate (SSC, 0 15 M NaCl and 
15 mM sodmm citrate, pH 7 0) 
Prehybndlzation was done m 50% formamldel5 x SCC (0 3 M NaCl, 
65 mM sodium &rate)/5 x Denhart’s solution (1 x Denhart’s solution 
1s 0 1% polyvmylpyrohdone, 0 1% Flcoll, 0 1% BSA)/20 mM sodium 
phosphate pH 6 8/O 1% SDS/lOO~g/ml denatured salmon sperm DNA 
overnight at 42°C Hybndlzatlon was done also at 42°C overnight m 
the same buffer, denatured labelled probes (lo’-lo7 cpm/ml) bemg 
added Radiolabelled probes were prepared by the random primer 
method (Boehnnger) The ubiqmtm probe used was a cDNA clone 
contammg 12 base pairs of the second ublqmtm coding sequence plus 
a complete third and fourth ublqmtm coding sequence and 120 base 
pairs of the 3’-untranslated reaon of the chicken polyutnqmtm gene 
UBI [7j An actm probe was used as a control of loading Filters were 
exposed to X Omat AR-5 films (Kodak) at 70°C for 2-4 days and the 
films quantified by laser densltometry 
2 9 Cathepszn actwtles 
The stored muscle samples were homogenized m 4 vols of 50 mM 
sodmm acetate pH 5 0 containing 0 2% Tnton X-100, 100 mM NaCl, 
1 mM EDTA, with a Polytron homogemzer The soluble extracts were 
obtained by centnfugatlon (32 000 x g, 4 mm, 4°C) Portions of the 
extracts were used for assaying enzyme activity Protein concentration 
of the extracts was assayed using the Bradford [9] method Cathepsms 
B was assayed with 5 mM Z-Arg-Arg-AMC at pH 6 0 Cathepsm H 
Table 1 
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was assayed with 5 mM H-Arg-AMC at pH 6 8 Cathepsm L activity 
was assayed with 2 mM Z-Phe-Arg-AMC at pH 5 5 Since this artificial 
substrate 1s not only hydrolyzed by cathepsm L but also cathepsm B 
at pH 5 5, its hydrolysis 1s expressed as the activity of cathepsm B + L 
In all cases, quantitatlon of enzyme activity was performed by measur- 
mg fluorlmetncally AMC liberation The fluorescence of liberated 
AMC was read m a Kontron SFM-25 fluonmeter at 350 nm (excitation 
wavelength) and 445 nm (emission wavelength) 
2 10 Statrstrcal analyszs 
StatIstical analysis of the data was performed by means of the Stu- 
dent’s t-test 
3. Results and discussion 
Many previous studies have described important 
changes m protem and amino acid metabolism in skeletal 
muscle of both human subjects and tumour-bearmg am- 
mals The mam changes involve enhanced proteolysls 
and decreased protein synthesis both of which explain 
the profound negative mtrogen balance encountered m 
neoplaslc states This phenomenon IS linked to the mus- 
cle wasting present m cachectlc cancer patients Our 
main obJective in this investigation was to assess which 
proteolytlc system (either lysosomal or non lysosomal) 
was involved m the referred muscle wastage. Bearmg this 
m mmd, we choose the Yoshlda AH-130 ascltes 
hepatoma which IS a highly cachectlc rat tumour of rapid 
growth and poorly differentiated cells. The tumour 1s 
characterized by a relatively short doubling time of one 
day [50], and 1s widely used m experimental studies 
3 I Body and tissue weights 
The lmplantatlon of the as&es tumour mfllcted lm- 
Body and tissue weights m rats bearmg the Yoshlda AH-130 ascites hepatoma 
Days after tumour transplantation 
Day 4 Day 7 
Pair-fed Tumour Ad hbltum-fed Pair-fed Tumour Ad hbltum-fed 
(6) (6) (5) (6) (7) (6) 
Initial body weight 172 f 2 173+3 166&4 178f2 182f2 174 +1 
Final body weight 181 f 2 180?3 185f5 174 ? 3*** 169 f 3***>+ 198 + 2 
Weight increase (%) 50fll 42+09 103?07 -3 5 f 0 7*** -7 1 + 1 (j***>ttt 134fl5 
Tissue weights 
Gastrocnemms 583 f 11 563 + 25 590 f 32 600 f 9* 547 f 15***,t 625 f 6 
Soleus 50f 1 47 f 2**,+++ 50 + 2 54_+ 3 43 f 1***,t+ 53f 1 
Liver 41+01* 5 0 * 0 2’f 47?02 3 3 f 0 1*** 4 2 f 0 27’ 46f02 
Tumour volume 15 f 1 51+2 
Cell number (~10~) 2192 f 145 4659 f 159 
For more details see the Expenmental section Body and hver weights are expressed m g Muscle weights are gven m mg Final body weight m 
tumour-bearmg animals represents the weight of the animal excluchng the tumour and ascltlc fluid Weight increase (%) and tissue weights are 
corrected per 100 g of metal body weight Tumour volume 1s expressed m ml Results are mean f S E M for the number of ammals indicated m 
parentheses Statistical significance of the results (by Students r-test), any group versus ad hbltum-fed *P < 0 05, **P < 0 01, ***P < 0 001, 
tumour-bearing versus pair-fed tP c 0 05, ttP c 0 01, tttP c 0 001 
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portant changes m body weight, as determined without 
the tumour, 7 days after maculation (Table 1). At this 
time point, both pair-fed and tumour-bearing animals 
weights were sigmficantly lower than ad hbitum-fed am- 
mals although the tumour-bearing rats showed a sigmfi- 
cantly lower body weight than the pair-fed ones (Table 
1) The increase m body weight was also sigmficantly 
lower m tumour-bearing and m pan-fed as compared to 
ad hbitum-fed rats, 4 and 7 days after tumor transplanta- 
tion (Table 1) These data clearly demonstrate that, al- 
though the decrease of food intake associated with tu- 
mour burden is responsible for a clear decrease m body 
weight, the presence of the tumour results m a further 
decrease m body weight, particularly noticeable when the 
tumour has reached its stationary growth phase [38] 
Muscle weights were also severely decreased by tu- 
mour growth as can be seen m Table 1. Gastrocnemms 
weights were decreased m all groups as compared with 
the ad hbitum-fed rats, the decrease being the greatest m 
the tumour-bearing animals (12%) 7 days after tumour 
transplantation Soleus weights were also significantly 
decreased both 4 and 7 days after transplantation (Table 
1). The decrease m muscle weights as a result of the 
Yoshida AH-l 30 ascites hepatoma have previously been 
reported [50] and it is clearly associated with an en- 
hanced proteolytic rate while no changes are observed m 
protein synthesis, as measured m viva [50] These 
changes m protein turnover seem to be triggered by TNF 
since anti-TNF treatment results m normal protein turn- 
over m AH-130 Yoshida-bearing rats [13] In addition, 
the cytokme does not seem to cause these effects directly 
[20] nor via mterleukm-1 (Costelh, P, Llovera, M., 
Garbo, N., Lopez-Soriano, F J & Argiles. J.M , unpub- 
lished results) nor via glucocorticoids (Costelh, P, Ll- 
overa, M , Garcia-Martinez, C , Lopez-Soriano, F J & 
Argiles, J M , unpublished results) The molecule(s) that 
mediate the actions of TNF on muscle protein turnover 
m this experimental tumour model is thus unknown 
Liver weights were significantly elevated m the tumour- 
bearing animals m relation to the pan-fed controls In- 
deed, tumour growth has been reported to result m en- 
larged liver size together with enhanced ammo acid up- 
take [224] for both liver protein synthesis and glu- 
coneogenesis [ 1,221 The livers of the pair-fed animals are 
smaller than those found m ad hbitum-fed animals 
(Table 1) Important changes m organ weight were also 
seen, 7 days after tumour transplantation, m the heart 
weight, tumour growth resulted m a decreased heart 
weight m relation with the pan-fed controls (319 ? 7 mg 
versus 283 + 3 mg (P < 0 001) for pair-fed and tumour- 
bearmg, respectively) 
reported [50]. Our intention here was to see whether the 
increased proteolysis was also observed m isolated mus- 
cles of these animals since this would indicate that their 
proteolytic machmery was constitually elevated, mde- 
pendently of any hormonal or humoral changes associ- 
ated with tumour burden The results presented m Table 
2 show that this was indeed the case smce the muscles 
from the tumour-bearmg ammals showed mcreased pro- 
teolytic rates both 4 (29%) and 7 (26%) days after tumour 
transplantation 
3 3 Cathepsm actwltles 
It has been proposed that lysosomal proteolytic sys- 
tems may be involved m protem turnover m skeletal 
muscle m pathological situations [23] while others have 
evidenced that myofibrillar protems are not the substrate 
of lysosomal protemases [35]. Takeda et al [48] have 
demonstrated an active participation of the cysteme pro- 
temases cathepsms B, H and L m xenografts of Duch- 
enne-muscular dystrophic muscles Although many stud- 
ies concern the participation of lysosomal protemases m 
tumour mvasion or metastasis (see Schmitt et al. [44] for 
review), few studies concern the role of cathepsms m 
muscle wastage associated with cancer Lundholm et al 
[36] clearly demonstrated the mvolvement of lysosomal 
protemases m the skeletal muscle of patients with a ma- 
lignant tumour. The same group also showed an increase 
m cathepsm D activity m hver and muscle of sarcoma- 
bearing mice [37] mdicatmg a direct role of cathepsms m 
muscle wastage associated with cancer cachexia Bearing 
these observations m mind. we evaluated the effects of 
the major cathepsms ystems m our tumour model The 
results presented m Table 3 show that only cathepsm H 
activity seems to be increased (16%) m gastrocnemms 
muscles of tumour-bearing ammals 4 days after tumour 
transplantation m relation to the pair-fed animals, while 
Table 2 
Proteolytlc rate m Isolated soleus muscles from tumour-bearing rat\ 
Experlmental group Proteolytlc rate 
Day 4 after transplantatlon 
Pair-fed 
Tumour 
194+65 
(7) 
251 f 11*** 
(6) 
Day 7 after transplantation 
Pair-fed 
Tumour 
192 ?r 5 
(5) 
242 f 13*** 
(5) 
3 2 Proteolytlc rate WI isolated muscles 
As previously mentioned, an enhanced proteolysis (m- 
creased fractional protein degradation rate) m gastrocne- 
mms muscles of AH- 130 Yoshida-bearmg rats has been 
For more detads see sectlon 2 All the mcubatlon media contained 500 
nM cyclohexlmlde The results are expressed as nmoles of tyrosme/g h 
and are mean f S E M with the number of ammals used m the different 
groups mdlcated m parentheses Statlstlcal slgmficance of the results 
***p < 0 001 
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Table 3 
Cathepsms enzymatic actwtles m gastrocnemms muscles of AH-130 Yoshlda-beanng rats 
Cathepsin 
Experimental group B B+L H 
Ad hbltum fed 700?031 
(6) 
Day 4 after transplantation 
Pair-fed 
Tumour 
5 50 f 0 46* 
(6) 
641 f 041 
(6) 
Day 7 after transplantation 
Pan-fed 
Tumour 
6 02 f 0 28* 
(7) 
4 11 * 0 40***‘+’ 
(6) 
10 6 + 0 53 
(6) 
11 1 f049 
(6) 
10 9 f 0 16 
(6) 
108fO64 
(7) 
7 74 + 0 24***9+++ 
(6) 
490&O 17 
(6) 
523fOlO 
(6) 
6 07 f 0 lS***>++’ 
(6) 
460fO17 
(7) 
471 f021 
(6) 
For more details see section 2 Enzymatic actwtles are expressed as nmoles of AMC/mm mg of muscle protein Results are mean f S E M for the 
number of animals mdicated m parentheses Statistical slgmficance of the results (by Student’s t test), any group versus ad hbltum-fed *P < 0 05, 
***P < 0 001, tumour-bearing versus pair-fed ++P < 0 01, +++P < 0 001 
no changes are observed 7 days after tumour growth 
(Table 3). The activities of cathepsins B and B + L were 
actually decreased in the tumour-bearing ammals, 7 days 
after tumour moculatlon as compared to both pair-fed 
(32% for B and 28% for B + L) and ad hbltum-fed (41% 
for B and 27% for B + L) animals (Table 3). Thus, it does 
not seem from the results presented that the mam cathep- 
an actlvltles, cathepsm H only seems to represent a 
minor activity m skeletal muscle [31], are directly m- 
volved m muscle wastage observed m this tumour model 
It has to be pointed out that both cathepsms B and B + L 
activities are decreased m the pair-fed controls m relation 
with ad hbitum-fed animals and this 1s probably the 
result of protein malnutrltlon as has been pointed out by 
Tawa et al [49]. 
3 4 Western blots 
Smce the lysosomal proteolytlc systems did not seem 
to be responsible for the enhanced muscle proteolysis 
observed m the Yoshlda AH-l 30-bearing rats, we de- 
cided to assess the partlclpatlon of other non-lysosomal 
protein degradation pathways uch as the ATP and ublq- 
mtm-dependent protease system Extracts of skeletal 
muscle, like those from other mammalian cells, contain 
the soluble ublqmtm-dependent proteolytlc system 
which 1s normally believed to catahze the rapid break- 
down of abnormal proteins and various short-lived nor- 
mal proteins [8,11,12] In this process, the carboxyl ter- 
minal of ublqultm is conjugated to protein substrates 
and this modlficatlon marks them for rapld degradation 
by a 1300 kDa complex [55] The role of ublqmtm-de- 
pendent proteolysls can be tested by exploiting the ublq- 
ultm moiety as an nnmunologlcal probe [27] of substrate 
specificity. The results presented in Table 4 show the 
Western blot quantitations of the free and conjugated 
ublqultm pools m both soleus and gastrocnemms mus- 
cles We used muscles from 7-day tumour-bearing rats 
since the largest changes m muscle weights were ob- 
served m this expenmental group. In gastrocnemms 
there was a significant increase for both free (53%) and 
Table 4 
Free and conjugated ublqultm in skeletal muscles of tumour-beanng rats 7 days after tumour moculatlon 
Type of muscle 
Expenmental group Gastrocnemius Soleus 
F C F 
Ad hbltum-fed 0 86 f 0 16 284fO15 1 17 f 0 18 
Pan--fed 081 f003 428fO60* 081 _+009 
Tumour 1 32 + 0 12*>++ 418fO60* 0 84 f 0 07 
C 
3442040 
4 37 -+ 0 26* 
7 45 + 0 09****+++ 
For further detads, see section 2 All data are expressed m arbitrary units/50 mg of protein and represent the mean _+ S E M of five different annnals 
F = free ubiqmtm, C = ConJugated ubiqmtm Statistical slgmficance of the results (by Student’s t-test), any group versus ad hbltum-fed *P < 0 05, 
***P c 0 001, tumor-beanng versus pair-fed ++P c 0 01, +++P c 0 001 
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C PF TB 
24kbb 
Ub 12kbb 
Actin 
EtBr 
% of control 
Fig 1 Northern blots of gastrocnemms muscle extracts from tumour- 
bearing rats Expresslon of ublqmtm mRNA m skeletal gastrocnemms 
muscles from ad hbltum-fed (C), pau-fed (PF) and tumour-bearmg rats 
(TB) at day 7 after tumour Implantation It was detected after hlbrldl- 
zatlon with a cDNA probe contammg aregion of the chlcken polyublq- 
mtm gene UBI (see sectlon 2) Autoradlographs were sublect to scan- 
mng densltometry. The results of 3 separate xperiments are shown and 
expressed as a percentage of ad hbltum-fed controls 
conlugated (42%) ubiquitm pools m relation with the ad 
hbitum-fed animals, while an important increase (63%) 
m free ubiquitm was also observed m relation to the 
fair-ped group (Table 4) In this muscle, pan-fed animals 
also showed an increased conlugation m relation with the 
ad hbitum-fed animals In soleus muscles, there was a 
marked tendency for lower values for both pan-fed 
(P = 0 11) and tumour-bearing (P = 0 12) m relation 
with the ad hbitum-fed animals, although the differences 
did not reach statistical significance In relation with the 
ConJugated ubiqmtin pools. both pan-fed (27%) and tu- 
mour-bearing (116%) showed higher values than the ad- 
hbitum-fed animals The presence of the tumour resulted 
m significantly elevated values m comparison with the 
pan-fed controls (Table 4). The changes observed with 
pan-feeding can be interpreted as an activation of non- 
lysosomal proteolysis induced by food restriction as has 
been previously reported [49] 
3 5 Ublqultm gene expresston 
Bearing m mmd the fact that very important changes 
m both free and conlugated ubiqmtm were observed m 
the tumour-bearing animals, we decided to assess the 
expression of the ubiqtntm gene m gastrocnemms mus- 
cles As shown m Fig 1, two polyubiquitm mRNA spe- 
cies (2.4 kb and 1 2 kb) and one ubiquitm-fusion protem 
mRNA (0 9 kb) were found m gastrocnemms muscle 
Tumour-bearing animals showed an increased expres- 
sion (over a 500%) of the polyubiquitin genes m relation 
to both pan-fed and ad hbitum-fed animals Conversely, 
no changes m the expression of ubiquitm-fusion protein 
and mRNA were observed m tumour-bearing animals 
(Figure 1) Since polyubiqumn genes have been shown 
to be increased m processes where an increase mtracellu- 
lar proteolysis is observed, these data, together with the 
enhanced ubiquitm conlugation of muscle proteins pres- 
ent m the tumour-bearing rats seem to indicate a role for 
the ATP-dependent proteolytic system m this tumour 
model In addition, our study, together with other obser- 
vations concerning the role of the ubiquitm-dependent 
proteolytic system m different pathological situations 
such as atrophy [39], contributes to alter the idea that 
this proteolytic system is a constrtuent system which 
merely degrades short-lived or abnormal proteins The 
system also appears to be responsible for the breakdown 
of most proteins m matured reticulocytes [46] and m 
growing fibroblasts [24] The present data thus suggest 
a more general role for this system m the degradation of 
normal muscle proteins, mcludmg, most likely, the long- 
lived myofibrillar components 
3 6 Concludmg remarks 
Tumour growth results m important changes m body 
weight mainly associated with decreases m adipose and 
muscular tissues leading to cachexia In the cachectic rat 
tumour model Yoshtda AH- 130 ascites hepatoma, mus- 
cle wastage is associated with an important increase m 
proteolysis while no changes are observed m the rate of 
protein synthesis [50] In this model we have previously 
reported that tumour necrosis factor-a (TNF) seems to 
be responsible for the enhanced proteolytic process [ 131 
This cytokme is also able to increase the ubiquitmization 
of skeletal muscle proteins m the rat [21] 
The results presented suggest hat the enhanced pro- 
M Llovera et al IFEBS Letters 338 (1994) 311-318 
tem degradation m the skeletal muscle of Yoshtda-bear- 
mg rats may to some extent be related to an increased 
ubiqmtm-dependent proteolytic system. In these animals 
the concentration of TNF 1s very elevated [13] and thus 
tt may be suggested that the cytokme could be triggering 
the enhanced expression of the ubiqmtm gene Further 
mvestigations are being undertaken to find out which is 
the mediator of the cytokme action on skeletal muscle, 
since TNF does not seem to have any direct effects on 
proteolysts m isolated muscles [20] 
The ATP-dependent proteolyttc system mvolves mul- 
tiple components mcludmg ubtqmtm, ubiquitm-conlu- 
gatmg enzymes and very large proteolytic complexes that 
require ATP, most of which are potential sides of regula- 
tion However, our knowledge of the regulation of this 
system 1s very primitive since only studies concernmg the 
effects of fasting and denervatton atrophy [30] have been 
performed, both mdtcatmg increases m gene expresston, 
most likely m response to hormonal mediators such as 
glucocorttcotds [56] This 1s the first study reporting that 
the ubtqmtm system is activated m response to tumour 
growth and that it may be involved m muscle wastage 
associated with cancer cachexia. This may lead to mter- 
estmg chmcal results since cachexta is responsible for at 
least 30% of deaths m cancer patients and, therefore, 
opens a field for future promtsmg research 
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